91 related articles for article (PubMed ID: 26237444)
1. Challenges in IPF diagnosis, current management and future perspectives: Patient case 2.
Margaritopoulos G
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():38-9. PubMed ID: 26237444
[TBL] [Abstract][Full Text] [Related]
2. Challenges in IPF diagnosis, current management and future perspectives: Patient case 1.
Egan J
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():36-7. PubMed ID: 26237443
[TBL] [Abstract][Full Text] [Related]
3. IPF, comorbidities and management implications: Patient case 2.
Hilberg O
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():26-7. PubMed ID: 26237441
[TBL] [Abstract][Full Text] [Related]
4. IPF, comorbidities and management implications: Patient case 1.
Kreuter M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():24-5. PubMed ID: 26237440
[TBL] [Abstract][Full Text] [Related]
5. Challenges in the classification of fibrotic ILD: Patient case 1.
Manali ED
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():10-2. PubMed ID: 26237437
[TBL] [Abstract][Full Text] [Related]
6. Challenges in IPF diagnosis, current management and future perspectives.
Wells AU; Costabel U; Poletti V; Crestani B; Egan J; Margaritopoulos G; Antoniou K
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():28-35. PubMed ID: 26237442
[TBL] [Abstract][Full Text] [Related]
7. Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).
Skaria SD; Yang J; Condos R; Smaldone GC
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):37-42. PubMed ID: 26237354
[TBL] [Abstract][Full Text] [Related]
8. Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough.
Thabut G; Crestani B; Porcher R; Richeldi L
Eur Respir J; 2015 Sep; 46(3):607-14. PubMed ID: 26324692
[No Abstract] [Full Text] [Related]
9. [Idiopathic pulmonary fibrosis--a case report].
Munteanu O
Pneumologia; 2010; 59(3):158-63. PubMed ID: 21058469
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the classification of fibrotic ILD: Patient case 2.
Wijsenbeek M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():13-6. PubMed ID: 26237438
[TBL] [Abstract][Full Text] [Related]
11. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Iwasawa T; Ogura T; Sakai F; Kanauchi T; Komagata T; Baba T; Gotoh T; Morita S; Yazawa T; Inoue T
Eur J Radiol; 2014 Jan; 83(1):32-8. PubMed ID: 22465123
[TBL] [Abstract][Full Text] [Related]
12. Features of usual interstitial pneumonia in patients with primary Sjögren׳s syndrome compared with idiopathic pulmonary fibrosis.
Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Okudela K; Yanagawa N; Baba T; Sakai F; Fukuda Y; Nagaoka S; Ogura T
Respir Investig; 2014 Jul; 52(4):227-35. PubMed ID: 24998369
[TBL] [Abstract][Full Text] [Related]
13. [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
Funke-Chambour M; Geiser T
Ther Umsch; 2016; 73(1):25-9. PubMed ID: 26884217
[TBL] [Abstract][Full Text] [Related]
14. Practical management of Idiopathic Pulmonary Fibrosis.
Kishaba T
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
[TBL] [Abstract][Full Text] [Related]
15. Supraventricular tachycardia and pulmonary hypertension at the presentation of Hodgkin's disease.
Korecki J; Kamiński KA; Lisowska A; Musiał WJ
Acta Cardiol; 2005 Dec; 60(6):655-7. PubMed ID: 16385929
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
Hashemi Sadraei N; Riahi T; Masjedi MR
Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
[TBL] [Abstract][Full Text] [Related]
17. Structured multidisciplinary discussion of HRCT scans for IPF/UIP diagnosis may result in indefinite outcomes.
Pezzuto G; Claroni G; Puxeddu E; Fusco A; Cavalli F; Altobelli S; Portalone S; Zompatori M; Simonetti G; Saltini C; Sergiacomi G
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):32-6. PubMed ID: 26237353
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
19. Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations.
Rabeyrin M; Thivolet F; Ferretti GR; Chalabreysse L; Jankowski A; Cottin V; Pison C; Cordier JF; Lantuejoul S
Ann Diagn Pathol; 2015 Aug; 19(4):269-76. PubMed ID: 26025258
[TBL] [Abstract][Full Text] [Related]
20. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis.
Kim WY; Mok Y; Kim GW; Baek SJ; Yun YD; Jee SH; Kim DS
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):289-96. PubMed ID: 25591140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
